Ticker
ESPRCompany Name
ESPERION THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 391.15M | $ 3.33M | $ 35.01M | $ 0 | -9.8% |
3/31/2025 | $ 176.99M | $ 9.55M | $ -4.08M | $ 0 | -3.09% |
12/31/2024 | $ 334.36M | $ 105.99M | $ -9.91M | $ 0 | -28.74% |
9/30/2024 | $ 415.74M | $ 115.11M | $ -49.52M | $ 0 | -15.78% |
6/30/2024 | $ 361.05M | $ 114.55M | $ -53.82M | $ 0 | -16.82% |
3/31/2024 | $ 449.02M | $ 109.78M | $ -18.23M | $ 0 | -20.39% |
12/31/2023 | $ 536.65M | $ 65.94M | $ -15.51M | $ 0 | -9.4% |
9/30/2023 | $ 117.13M | $ 78.86M | $ -63.25M | $ 0 | -13.33% |
6/30/2023 | $ 180.82M | $ 127.55M | $ -61.32M | $ 0 | -36.62% |
3/31/2023 | $ 134.49M | $ 143.45M | $ -59.91M | $ 0 | -62.11% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for ESPERION THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 13.41M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 24.89M ]) / Market Cap [ $ 808.14M ]
(=) Shareholder Yield [ -4.74% ]
Minimum
Dec 31, 2021
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.56% |
median | 1.07% |
std | 11.12% |